IMDX Reports Q3 2025 Results and Progress Toward 2026 Commercial Launch
Provided By GlobeNewswire
Last update: Nov 10, 2025
NASHVILLE, Tenn., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today published the following letter to shareholders in conjunction with its third quarter results:
Read more at globenewswire.comNASDAQ:IMDX (11/13/2025, 12:51:34 PM)
8.02
-0.46 (-5.42%)
Find more stocks in the Stock Screener
IMDX Latest News and Analysis
3 days ago - By: Chartmill
